EyePoint Pharmaceuticals
Watertown
About EyePoint Pharmaceuticals
EyePoint Pharmaceuticals develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. The company have developed three approved products in either the U.S. or the EU for sustained release delivery of drug utilizing multiple generations of our Durasert technology system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $803.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:EYPT
- Website: eyepointpharma.com
- Phone: 617-926-5050
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/eyepoint-pharmaceuticals-54374 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.